Being a non-invasive blood-based test, Trucheck™ can minimize the need to visit a healthcare centre – since the blood sample can also be collected from the privacy and comfort of your home.
Advantages to the individuals:
Wait times for appointments are reduced
Minimized risk of COVID exposure
May be assimilated into annual health check-up
No risk of radiation or those associated with invasive procedures
Advantages to the system:
Reduces risk of COVID transmission and exposure of staff
Reductions in avoidable / non-critical appointments
Minimizes procedures that may be retrospectively deemed unnecessary
Supports decision making in conjunction with existing tests / methods
Trucheck™ Pragma can Detect 5 Types of Cancers
Trucheck™-Pragma test is intended for early detection of Lung, Stomach, Colon, Pancreas, Prostate, Breast and Ovarian cancers.
Why should I consider Trucheck™?
Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals. Trucheck™ technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants.
The test is a paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at our world-class laboratory, which meets and exceeds all national and international standards.
Trucheck™ is Accurate
The Development of Trucheck™ includes extensive Analytical and Clinical validation studies to establish its Accuracy and Reliability.
Trucheck™ has been clinically proven to have accuracy of > 90% in detecting cancer early. Trucheck™ has high accuracy to localize the tissue of origin.
Ask Your Doctor
Our patient's downloadable content has all the information you and your doctor need to discuss Trucheck™ testing.